Convatec Sees Margin Improvement in H2 as Infusion Demand Strengthens
Convatec Group PLC said it expects materially higher operating margins in the second half of 2026 compared with the first half, citing rising demand for its infusion care products. The medical products maker reiterated its outlook for double-digit earnings growth, adjusted its full-year organic revenue guidance excluding InnovaMatrix, and announced…